Dr. Lal PathLabs has informed that the Board of Directors in their meeting held today i.e. April 25, 2025, considered and approved the following(s): Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Financial Year ended March 31, 2025. A signed copy of the above Financial Results (Standalone & Consolidated) along with Auditors’ Reports thereon is attached as ‘Annexure -A’ and a declaration under Regulation 33 of the Listing Regulations, signed by Group Chief Financial Officer in respect of Audit Reports issued by Statutory Auditors with un-modified opinion is attached herewith as ‘Annexure- B’; Recommendation of final dividend of INR 6 per equity share (@ 60% on a face value of INR 10 each) for the financial year ended March 31, 2025, subject to approval of the Members of the Company at ensuing Annual General Meeting (AGM). The record date for the purpose of payment of final dividend shall be June 06, 2025; Re-appointment of Mr. Rohit Bhasin (DIN: 02478962) as a Non-Executive Independent Director of the Company, for a period of five (5) consecutive years commencing from November 08, 2025 subject to approval of Members of the Company at the ensuing AGM; Re-appointment of. Arun Duggal (DIN: 00024262) as a Non-Executive Independent Director of the Company, for a period of three (3) consecutive years commencing from February 02, 2026, subject to approval of Members of the Company at the ensuing AGM.

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

3025.95 -28.50 (-0.93%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×